CVRx, Inc. (CVRX) stock
CVRXNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 8/3093% below fair value
$0.50−0.03 (-5.99%)
Close on Nov 20, 2026Market cap $13.35MP/E –Yield –
CVRx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
CVRx's gross profit for the twelve months ending Jun 30, 2026 was $53.18M, up 16.5% year over year. For fiscal 2025 it was $48.34M, up 12.5% from the year before. The highest annual figure on record is $48.34M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $48.34M | +12.5% |
| FY2024 | Dec 31, 2024 | $42.96M | +30.0% |
| FY2023 | Dec 31, 2023 | $33.04M | +89.1% |
| FY2022 | Dec 31, 2022 | $17.47M | +85.9% |
| FY2021 | Dec 31, 2021 | $9.40M | +103.7% |
| FY2020 | Dec 31, 2020 | $4.61M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $13.72M | +19.9% |
| Q1 FY2026 | Mar 31, 2026 | $12.88M | +24.9% |
| Q4 FY2025 | Dec 31, 2025 | $13.83M | +8.3% |
| Q3 FY2025 | Sep 30, 2025 | $12.75M | +14.6% |
| Q2 FY2025 | Jun 30, 2025 | $11.45M | +15.6% |
| Q1 FY2025 | Mar 31, 2025 | $10.31M | +12.6% |
| Q4 FY2024 | Dec 31, 2024 | $12.77M | +33.2% |
| Q3 FY2024 | Sep 30, 2024 | $11.13M | +26.1% |
| Q2 FY2024 | Jun 30, 2024 | $9.91M | +24.1% |
| Q1 FY2024 | Mar 31, 2024 | $9.16M | +37.6% |
| Q4 FY2023 | Dec 31, 2023 | $9.59M | +69.1% |
| Q3 FY2023 | Sep 30, 2023 | $8.82M | +82.0% |
| Q2 FY2023 | Jun 30, 2023 | $7.98M | +108.4% |
| Q1 FY2023 | Mar 31, 2023 | $6.65M | +112.7% |
| Q4 FY2022 | Dec 31, 2022 | $5.67M | +111.9% |
| Q3 FY2022 | Sep 30, 2022 | $4.85M | +92.4% |
| Q2 FY2022 | Jun 30, 2022 | $3.83M | +73.3% |
| Q1 FY2022 | Mar 31, 2022 | $3.13M | +56.9% |
| Q4 FY2021 | Dec 31, 2021 | $2.67M | +63.3% |
| Q3 FY2021 | Sep 30, 2021 | $2.52M | +220.9% |
| Q2 FY2021 | Jun 30, 2021 | $2.21M | +144.2% |
| Q1 FY2021 | Mar 31, 2021 | $1.99M | – |
| Q4 FY2020 | Dec 31, 2020 | $1.64M | – |
| Q3 FY2020 | Sep 30, 2020 | $785.00K | – |
| Q2 FY2020 | Jun 30, 2020 | $905.00K | – |
See a number that looks wrong?